Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA small bruise at the injection site is one of the most common things people notice after their first few Wegovy pens. It usually fades within a few days, needs no treatment, and does not mean anything has gone wrong with your dose. That said, there are some straightforward techniques that make bruising less likely, and a handful of signs worth knowing about. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It happens more often than people expect. You've done everything the instructions say, the pen clicks, you count to ten, and still, a purplish mark appears within a minute or two. This is bruising, and it is a recognised injection-site reaction for subcutaneous medicines, Wegovy included. The NHS page on semaglutide lists injection-site bruising among the common local reactions, so you are in well-documented company.
The reason is straightforward anatomy. Subcutaneous tissue is threaded with fine capillaries, and a needle will occasionally nick one. Blood then seeps into the surrounding tissue before clotting. Most bruises from weekly injections are small (a centimetre or two across) and clear up in three to five days without any intervention. They are not a sign that the semaglutide has gone somewhere it shouldn't, and they do not affect how well the medicine works.
What does make a difference is technique, timing, and site choice. A question our prescribers hear regularly is whether the size of the bruise means something went wrong; almost always, the answer is no. Good injection technique reduces how often it happens but rarely eliminates it entirely.
One of the most consistent patterns: bruising is more common when people inject immediately after taking the pen from the fridge. Cold semaglutide is thicker, and cold tissue contracts around the needle tip, both raise the chance of a small bleed. Leaving the pen at room temperature for fifteen to twenty minutes before injecting is a simple fix. If you are considering injectii de slabit Wegovy, understanding how pen temperature affects the injection experience is a useful early step. The Wegovy pen you receive arrives in a plain, unbranded box via tracked DPD delivery; the pen itself goes straight into the fridge, but on injection day, set it out while you make a coffee.
Beyond temperature, a few other habits help. Pressing an alcohol swab to the site before injecting is good hygiene practice; just let the skin dry fully before the needle goes in, because wet alcohol on a fresh puncture stings and can cause local irritation. After the injection, gentle pressure with a clean finger for thirty seconds (without rubbing) encourages clotting. Rubbing spreads any small bleed wider. Rotating sites methodically matters too: the same spot every week will bruise and toughen over time. You can read more about bruising patterns across injection sessions and how rotation reduces cumulative skin changes.
If you are injecting into the abdomen, keep clear of the two-inch zone immediately around the navel, the tissue there is more vascular. The outer thigh and the back of the upper arm are often less prone to visible bruising for people who find the abdomen consistently marks.
Most bruises need nothing but time. There are some patterns, though, that warrant a proper conversation with your prescriber rather than a wait-and-see approach. If you notice a bruise at your Wegovy injection site that grows beyond about 4–5 cm, feels firm or hot to the touch, or arrives with significant pain beyond the first hour, that is outside the normal range. Swelling that spreads away from the injection site (particularly if accompanied by redness, warmth, or flu-like symptoms) could indicate a localised infection, which needs prompt assessment.
People who take blood-thinning medicines (anticoagulants or even regular aspirin) bruise more readily from any subcutaneous injection and may notice marks that look dramatic but are still benign; flagging this to your prescriber before starting treatment allows them to take it into account. Our dedicated page on bruising at injection site Wegovy covers some of those patterns in more depth.
You can report any suspected side effect, including unusual injection-site reactions, through the MHRA's Yellow Card scheme, a public record that helps regulators track real-world safety signals. It is open to patients, not just healthcare professionals, and takes around five minutes.
If you are switching between injection sites or considering whether pen storage might be contributing, the guidance on injecting Wegovy straight from the fridge covers the storage-to-injection window in more detail. For anyone still weighing up whether weekly injections are the right route at all, the weight-loss treatment overview sets out how the different licensed options compare.
Ongoing bruising that disrupts your weekly routine is also a fair thing to raise in a check-in. At nume, our clinical team reviews every repeat order before it is dispatched, it is a natural point to ask questions about technique or site rotation. If you would like to speak to one of our prescribers about anything covered here, you are welcome to start a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.